Paratek Pharmaceuticals
PRTK
#9026
Rank
S$0.16 B
Marketcap
S$2.89
Share price
0.00%
Change (1 day)
11.55%
Change (1 year)

Earnings for Paratek Pharmaceuticals (PRTK)

Earnings in 2023 (TTM): -S$60.09 Million

According to Paratek Pharmaceuticals 's latest financial reports the company's current earnings are S$0.16 Billion. In 2022 the company made an earning of -S$58.78 Million a decrease over its 2021 earnings that were of -S$53.19 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Paratek Pharmaceuticals from 2004 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -S$60.09 Million2.23%
2022 -S$58.78 Million10.5%
2021 -S$53.19 Million-46.16%
2020 -S$98.8 Million-31.93%
2019 -S$0.15 Billion11.12%
2018 -S$0.14 Billion21.19%
2017 -S$0.11 Billion-23.22%
2016 -S$0.15 Billion54.68%
2015 -S$90.76 Million309.5%
2014 -S$22.17 Million-29.88%
2013 -S$31.61 Million
2011 -S$4.88 Million-59.18%
2010 -S$11.95 Million-53.53%
2009 -S$25.7 Million-161.93%
2008 S$41.49 M-187.43%
2007 -S$47.46 Million11.93%
2006 -S$42.4 Million31.69%
2005 -S$32.2 Million32.4%
2004 -S$24.32 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Spectrum Pharmaceuticals
SPPI
-S$80.13 Million 41.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
S$26.75 M-147.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-S$0.68 Billion 1,086.69%๐Ÿ‡บ๐Ÿ‡ธ USA